Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JPMA to Gear Up Efforts to Protect IP
October 7, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 7, 2002
- Dr Sakaguchi Shows Direction for Medical Fee System Reform: Economist Conferences
October 7, 2002
- Sales Up, But Gross Profit Margin Down 4.14%: FJPWA Survey
October 7, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
October 7, 2002
- Effects of Generics Use-Promotion Policy Remain Unpredictable: EMA
October 7, 2002
- Iino in Saitama Joins AEON Welcia Group
October 7, 2002
- BUSINESS NEWS IN BRIEF
October 7, 2002
- Association to Support Studies of Health Food in Humans
October 7, 2002
- Health Minister Presents Personal Proposals for Healthcare Reform
October 7, 2002
- Drug Retailers Should Promote Self-medication: NMRA Meeting
October 7, 2002
- Korosho to Reorganize PFSB
October 7, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 7, 2002
- Mr Miyauchi Criticizes Korosho for Its Opposition to Deregulation
October 7, 2002
- Nippon Keidanren Calls For Simplification of Application for Medical Devices
October 7, 2002
- PFSB to Accelerate Introduction of Fast-Track System
October 7, 2002
- Olympus Sets Up Marketing Subsidiary in Sao Paulo
October 7, 2002
- Drugs for 21st Quality Reevaluation Announced
October 7, 2002
- Olympus: New Reaction/Analysis System FD10
October 7, 2002
- Results of Reexamination for 22 Active Ingredients Announced
October 7, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…